Anginera (Theregen)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameAnginera (Theregen)
Drug Alias NameEpicardial angiogenesis patchAnginera
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionTissue replacementsAngiogenesis inducers
TargetsNot applicable
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTheregen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheregen Inc
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A